BPI26-032: Safety and Outcomes of Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in GI/GU Metastases With Cancer Associated Thrombosis
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Omer Ashruf und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Indiana University, Department of Internal Medicine, Indianapolis, IN.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Indiana University, Department of Internal Medicine, Indianapolis, IN.
- 2MetroHealth Medical Center, Cleveland, OH.
- 3Cleveland Clinic, Department of Medicine, Cleveland, OH.
Zitieren
APA
Ashruf, O., Kaurich, Q., Verbrugge, M., Kaelber, D. C., & Mushtaq, A. (2026). BPI26-032: Safety and Outcomes of Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in GI/GU Metastases With Cancer Associated Thrombosis. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7226
Vancouver
Ashruf O, Kaurich Q, Verbrugge M, Kaelber DC, Mushtaq A. BPI26-032: Safety and Outcomes of Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in GI/GU Metastases With Cancer Associated Thrombosis. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7226
BibTeX
@article{Ashruf2026,
author = {Ashruf, Omer and Kaurich, Quinn and Verbrugge, Maxwell and Kaelber, David C and Mushtaq, Ali},
title = {BPI26-032: Safety and Outcomes of Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in GI/GU Metastases With Cancer Associated Thrombosis},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7226}
}
EUVIMED